UC Health Offers New Uterine Fibroid Treatment in Cincinnati
Uterine fibroids affect a significant number of women, causing symptoms ranging from heavy bleeding and pain to infertility. For women in Cincinnati, UC Health is now providing a revolutionary, minimally invasive treatment option that promises quicker recovery and preserved fertility. This advancement marks a new era for managing a common, often debilitating condition right here in our community.
Understanding Uterine Fibroids and Traditional Treatments
Uterine fibroids are non-cancerous growths that develop in the uterus, varying greatly in size and number. They are incredibly common, with up to 80% of women experiencing them by age 50, though not all will have symptoms. For those who do, symptoms can include heavy or prolonged menstrual bleeding, pelvic pain or pressure, frequent urination, constipation, backache or leg pains, and complications with pregnancy or fertility. Historically, treatment options have ranged from watchful waiting and medication to more invasive surgical procedures like myomectomy (surgical removal of fibroids) or, in severe cases, hysterectomy (removal of the uterus). While effective, these traditional surgeries often involve longer recovery times and, in the case of hysterectomy, the loss of reproductive capability.
Introducing the Acessa ProVu System at UC Health
Cincinnati women now have access to a groundbreaking alternative: the Acessa ProVu System. UC Health is the first institution in the region to offer this state-of-the-art treatment. The Acessa procedure is a minimally invasive, laparoscopic radiofrequency ablation technique that precisely targets and shrinks fibroids. During the procedure, a small probe is inserted into each fibroid, and radiofrequency energy is used to heat and destroy the fibroid tissue. Over time, the treated fibroids shrink and are reabsorbed by the body, alleviating symptoms. The procedure is performed under general anesthesia and typically involves only a few small incisions, reducing post-operative pain and scarring compared to traditional open surgery.
Key Benefits and Implications for Local Women
The introduction of the Acessa ProVu System at UC Health carries significant implications for women in Greater Cincinnati. The primary advantage is its minimally invasive nature, which translates to a much faster recovery time—often just a few days compared to several weeks for a myomectomy. Crucially, the Acessa procedure preserves the uterus, making it an excellent option for women who wish to retain their fertility or simply avoid a hysterectomy. Furthermore, clinical studies have shown that this innovative approach not only effectively treats existing fibroids but also significantly reduces the likelihood of new fibroids developing, offering a more long-term solution for many patients. This local availability ensures that women can receive advanced care without traveling far from home, supported by the expertise of UC Health’s specialists, including Dr. Elizabeth South, a reproductive endocrinology and infertility specialist who is instrumental in bringing this treatment to the region.
Comparing Treatment Options: Acessa ProVu vs. Traditional Surgery
To help understand the distinct advantages, here’s a brief comparison of common fibroid treatments:
| Feature | Acessa ProVu System | Laparoscopic Myomectomy | Abdominal Hysterectomy |
|---|---|---|---|
| Invasiveness | Minimally invasive (small incisions) | Minimally invasive (small incisions) | Invasive (larger abdominal incision) |
| Uterus Preservation | Yes | Yes | No (uterus removed) |
| Recovery Time | Typically 3-5 days | Typically 2-4 weeks | Typically 4-6 weeks |
| Fibroid Treatment | Shrinks and ablates fibroids | Surgically removes fibroids | Removes uterus and all fibroids |
| Future Fibroids | Reduced likelihood of new growth | Possible regrowth | Not applicable |
What to Watch Next in Women’s Health
The adoption of the Acessa ProVu System by UC Health reinforces its commitment to being a leader in women’s health and minimally invasive surgery in the Cincinnati area. This technology’s success may pave the way for broader adoption of similar innovative procedures across the region, offering more choices for patients facing complex gynecological conditions. We can expect UC Health to continue exploring and implementing advanced medical solutions that prioritize patient well-being, shorter recovery times, and improved quality of life. For women suffering from fibroid symptoms, this signifies a hopeful future with more effective, less disruptive treatment paths becoming readily available.
Frequently Asked Questions About Acessa ProVu
- What are uterine fibroids?
Uterine fibroids are common, non-cancerous growths that form in or on the wall of the uterus, often causing symptoms like heavy bleeding, pain, or pressure. - How is the Acessa ProVu System different from other treatments?
Acessa ProVu is a minimally invasive, uterus-preserving procedure that uses radiofrequency energy to ablate (heat and destroy) fibroid tissue from within, leading to their shrinkage. Unlike myomectomy, it doesn’t involve cutting out fibroids, and unlike hysterectomy, it preserves the uterus. - Am I a candidate for the Acessa ProVu procedure?
Women experiencing symptoms from uterine fibroids who wish to preserve their uterus and avoid more invasive surgery may be candidates. It is suitable for most types and locations of fibroids, up to a certain size. A consultation with a UC Health specialist is necessary to determine eligibility. - Where can I receive this treatment in Cincinnati?
The Acessa ProVu System is now available at UC Health, making it the first institution in the Cincinnati region to offer this advanced procedure. - What is the typical recovery time?
Patients typically experience a recovery time of 3-5 days before resuming normal activities, significantly shorter than traditional open surgical options for fibroid removal.
If you’re a woman in Cincinnati experiencing the challenges of uterine fibroids, discussing the Acessa ProVu System with your gynecologist at UC Health could open up a new, less invasive path to symptom relief and improved quality of life.
UC Health Revolutionizes Fibroid Care in Cincinnati
